News:

This week IPhone 15 Pro winner is karn
You can be too a winner! Become the top poster of the week and win valuable prizes.  More details are You are not allowed to view links. Register or Login 

Main Menu

Analysis: Antibiotics crisis prompts rethink on risks, rewards

Started by riky, March 19, 2013, 08:00:15 AM

Previous topic - Next topic

0 Members and 1 Guest are viewing this topic.

riky

Analysis: Antibiotics crisis prompts rethink on risks, rewards

<p><a href="http://news.yahoo.com/analysis-antibiotics-crisis-prompts-rethink-risks-rewards-163939554.html"><img src="http://l3.yimg.com/bt/api/res/1.2/oPnThphSg5GYTFzmfk5Tbg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-03-18T163939Z_1_CBRE92H1AAA00_RTROPTP_2_HEALTH-ANTIBIOTICS.JPG" width="130" height="86" alt="File photo of test tubes filled with samples of bacteria to be tested at Health Protection Agency in north London" align="left" title="File photo of test tubes filled with samples of bacteria to be tested at Health Protection Agency in north London" border="0" /></a>By Ben Hirschler LONDON (Reuters) - Thirty years ago, when the world faced the terrifying prospect of an untreatable disease known as AIDS, big drugmakers scented an opportunity and raced to develop new medicines. Today, as the world confronts another crisis, this time one of antibiotic resistance, the industry is doing the opposite. It is cutting research in a field that offers little scope for making money. Antibiotics have become victims of their own success. Seen as cheap, routine treatments, they are overprescribed and taken haphazardly, creating &quot;superbugs&quot; they can no longer fight. ...</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login
You are not allowed to view links. Register or Login